SCHEMBL14321692

SCHEMBL14321692

CC(C)(C)c1cc2c(Br)cnc(Cl)c2n1C(N)=O

nearest known ligand 0.30

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 1/20 0.30
▸ LMNA P02545 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30069326 0.72 PIK3CA (0.33) —
SCHEMBL2369513 0.68 PARP1 (0.36) —
SCHEMBL14321691 0.62 BCHE (0.33) —
SCHEMBL25321738 0.60 — —
SCHEMBL19278217 0.60 ALDH1A1 (0.35) ALDH1A1LMNA
SCHEMBL25320029 0.59 PDE2A (0.33) ALDH1A1LMNA
SCHEMBL16011544 0.59 CDK8 (0.57) —
SCHEMBL19268782 0.59 ALDH1A1 (0.34) ALDH1A1
SCHEMBL25324020 0.58 PDE2A (0.33) ALDH1A1LMNA
SCHEMBL30867441 0.58 POLB (0.43) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120329826-A1 SUBSTITUTED-5-AMINOPYRROLO/PYRAZOLOPYRIDINES OSI Pharmaceuticals,. LLC 2012-12-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120329826-A1 SUBSTITUTED-5-AMINOPYRROLO/PYRAZOLOPYRIDINES MET, KRAS, VHL ALDH1A1 62/4885LMNA 4238/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback